Morning Briefing
Summaries of health policy coverage from major news organizations
MSF Warns Global Shortage Of Drug-Resistant TB Treatment Likely
As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, "enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns," according to PlusNews.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
